Stocks & Investing
Stocks and Investing
Stocks and Investing
Mon, August 7, 2023
[ Mon, Aug 07th 2023
] - WOPRAI
[ Mon, Aug 07th 2023
] - WOPRAI
[ Mon, Aug 07th 2023
] - WOPRAI
[ Mon, Aug 07th 2023
] - WOPRAI
[ Mon, Aug 07th 2023
] - WOPRAI
[ Mon, Aug 07th 2023
] - WOPRAI
[ Mon, Aug 07th 2023
] - WOPRAI
[ Mon, Aug 07th 2023
] - WOPRAI
[ Mon, Aug 07th 2023
] - WOPRAI
[ Mon, Aug 07th 2023
] - WOPRAI
[ Mon, Aug 07th 2023
] - WOPRAI
[ Mon, Aug 07th 2023
] - WOPRAI
[ Mon, Aug 07th 2023
] - WOPRAI
[ Mon, Aug 07th 2023
] - WOPRAI
[ Mon, Aug 07th 2023
] - WOPRAI
[ Mon, Aug 07th 2023
] - WOPRAI
[ Mon, Aug 07th 2023
] - WOPRAI
[ Mon, Aug 07th 2023
] - WOPRAI
[ Mon, Aug 07th 2023
] - WOPRAI
[ Mon, Aug 07th 2023
] - WOPRAI
[ Mon, Aug 07th 2023
] - WOPRAI
[ Mon, Aug 07th 2023
] - WOPRAI
[ Mon, Aug 07th 2023
] - WOPRAI
[ Mon, Aug 07th 2023
] - WOPRAI
[ Mon, Aug 07th 2023
] - WOPRAI
[ Mon, Aug 07th 2023
] - WOPRAI
[ Mon, Aug 07th 2023
] - WOPRAI
[ Mon, Aug 07th 2023
] - WOPRAI
[ Mon, Aug 07th 2023
] - WOPRAI
Xiling Chen Maintained (BGNE) at Buy with Increased Target to $300 on, Aug 7th, 2023
Xiling Chen of JP Morgan, Maintained "BeiGene, Ltd." (BGNE) at Buy with Increased Target from $297 to $300 on, Aug 7th, 2023.
Xiling has made no other calls on BGNE in the last 4 months.
There are 3 other peers that have a rating on BGNE. Out of the 3 peers that are also analyzing BGNE, 2 agree with Xiling's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Rebecca Liang of "Bernstein" Downgraded from Buy to Hold and Decreased Target to $196 on, Friday, June 30th, 2023
- David Li of "B of A Securities" Maintained at Hold with Increased Target to $263 on, Wednesday, April 12th, 2023
This is the rating of the analyst that currently disagrees with Xiling
- Yigal Nochomovitz of "Citigroup" Initiated at Strong Buy and Held Target at $275 on, Monday, July 17th, 2023
